FDA Warning Letter — Row1 Inc.

Case 638823 — FEI 3016750083

The FDA took a Warning Letter action against Row1 Inc. on June 21, 2023 (Pensacola, FL). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Row1 Inc.
Date
June 21, 2023
Fiscal Year
2023
Product Type
Biologics
Center
CBER
Location
Pensacola, FL (United States)